RpoS contributes to phagocyte oxidase-mediated stress resistance during urinary tract infection by Escherichia coli CFT073

mBio

Volumn 4, Issue 1, 2013, Pages

  Hryckowian, Andrew J ^a   Welch, Rodney A ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OXIDOREDUCTASE; PEROXIDE; SIGMA FACTOR RPOS; BACTERIAL PROTEIN; SIGMA FACTOR; SIGMA FACTOR KATF PROTEIN, BACTERIA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIUM COLONY; CELL FUNCTION; CELLULAR STRESS RESPONSE; CONTROLLED STUDY; ESCHERICHIA COLI INFECTION; FRAMESHIFT MUTATION; HOST PATHOGEN INTERACTION; HUMAN; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SENSITIVITY ANALYSIS; URINARY TRACT INFECTION; URINE LEVEL; UROPATHOGENIC ESCHERICHIA COLI; ANIMAL; C57BL MOUSE; CBA MOUSE; DISEASE MODEL; DRUG EFFECT; ENZYMOLOGY; GENE DELETION; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; METABOLISM; MICROBIOLOGY; PHAGOCYTE; PHYSIOLOGICAL STRESS;

ANIMALS; BACTERIAL PROTEINS; DISEASE MODELS, ANIMAL; ESCHERICHIA COLI INFECTIONS; GENE DELETION; GENE EXPRESSION REGULATION, BACTERIAL; HOST-PATHOGEN INTERACTIONS; MICE; MICE, INBRED C57BL; MICE, INBRED CBA; OXIDATIVE STRESS; OXIDOREDUCTASES; PHAGOCYTES; SIGMA FACTOR; STRESS, PHYSIOLOGICAL; URINARY TRACT INFECTIONS; UROPATHOGENIC ESCHERICHIA COLI;

MLCS; MLOWN;

EID: 84874601616     PISSN: 21612129     EISSN: 21507511     Source Type: Journal    
DOI: 10.1128/mBio.00023-13     Document Type: Article

References (40)

1. Kucheria R, Dasgupta P, Sacks SH, Khan MS, Sheerin NS. 2005. Urinary tract infections: new insights into a common problem. Postgrad. Med. J. 81:83-86. http://dx.doi.org/10.1136/pgmj.2004.023036.
2. Foxman B. 1990. Recurring urinary tract infection: incidence and risk factors. Am. J. Public Health 80:331-333. http://dx.doi.org/10.2105/AJPH.80.3.331.
3. O'Hanley P. 1996. Prospects for urinary tract infection vaccines, p 405-425. In Mobley HL, Warren JW (ed.), Urinary tract infections: molecular pathogenesis and clinical management. ASM Press, Washington, DC.
4. Foxman B. 2010. The epidemiology of urinary tract infection. Nat. Rev. Urol. 7:653-660. http://dx.doi.org/10.1038/nrurol.2010.190.
5. Haraoka M, Hang L, Frendéus B, Godaly G, Burdick M, Strieter R, Svanborg C. 1999. Neutrophil recruitment and resistance to urinary tract infection. J. Infect. Dis. 180:1220-1229. http://dx.doi.org/10.1086 /315006.
6. Babior BM. 2000. Phagocytes and oxidative stress. Am. J. Med. 109: 33-44. http://dx.doi.org/10.1016/S0002-9343(00)00481-2.
7. Yang HC, Cheng ML, Ho HY, Chiu DT. 2011. The microbicidal and cytoregulatory roles of NADPH oxidases. Microbes Infect. 13:109-120.
8. Fang FC. 2004. Antimicrobial reactive oxygen and nitrogen species: concepts and controversies. Nat. Rev. Microbiol. 2:820-832. http://dx.doi.org/10.1038/nrmicro1004.
9. Altenhöfer S, Kleikers PW, Radermacher KA, Scheurer P, Rob Hermans JJ, Schiffers P, Ho H, Wingler K, Schmidt HH. 2012. The NOX toolbox: validating the role ofNADPHoxidases in physiology and disease. Cell. Mol. Life Sci. 69:2327-2343. http://dx.doi.org/10.1007/s00018-012-1010-9.
10. De Groote MA, Fang FC. 1999. Antimicrobial properties of nitric oxide, p 231-261. In Fang FC (ed.), Nitric oxide and infection. Academic Plenum Press, New York, NY.
11. Nathan C, Shiloh MU. 2000. Reactive oxygen and nitrogen intermediates in the relationship between mammalian hosts and microbial pathogens. Proc. Natl. Acad. Sci. U. S. A. 97:8841-8848. http://dx.doi.org/10.1073 /pnas.97.16.8841.
12. Rama G, Chhina DK, Chhina RS, Sharma S. 2005. Urinary tract infections-microbial virulence determinants and reactive oxygen species. Comp. Immunol. Microbiol. Infect. Dis. 28:339-349. http://dx.doi.org /10.1016/j.cimid.2005.09.002.
13. Gruber TM, Gross CA. 2003. Multiple sigma subunits and the partitioning of bacterial transcription space. Annu. Rev. Microbiol. 57:441-466. http://dx.doi.org/10.1146/annurev.micro.57.030502.090913.
14. Weber H, Polen T, Heuveling J, Wendisch VF, Hengge R. 2005. Genome-wide analysis of the general stress response network in Escherichia coli: sigmas-dependent genes, promoters, and sigma factor selectivity. J. Bacteriol. 187:1591-1603. http://dx.doi.org/10.1128/JB.187.5.1591-1603.2005.
15. Eisenstark A, Calcutt MJ, Becker-Hapak M, Ivanova A. 1996. Role of Escherichia coli rpoS and associated genes in defense against oxidative damage. Free Radic. Biol. Med. 21:975-993. http://dx.doi.org/10.1016 /S0891-5849(96)00154-2.
16. Lange R, Hengge-Aronis R. 1991. Identification of a central regulator of stationary-phase gene expression in Escherichia coli. Mol. Microbiol. 5:49-59. http://dx.doi.org/10.1111/j.1365-2958.1991.tb01825.x.
17. Battesti A, Majdalani N, Gottesman S. 2011. The RpoS-mediated general stress response in Escherichia coli. Annu. Rev. Microbiol. 65:189-213. http://dx.doi.org/10.1146/annurev-micro-090110-102946.
18. Levert M, Zamfir O, Clermont O, Bouvet O, Lespinats S, Hipeaux MC, Branger C, Picard B, Saint-Ruf C, Norel F, Balliau T, Zivy M, Le Nagard H, Cruveiller S, Chane-Woon-Ming B, Nilsson S, Gudelj I, Phan K, Ferenci T, Tenaillon O, Denamur E, Denamur E. 2010. Molecular and evolutionary bases of within-patient genotypic and phenotypic diversity in Escherichia coli extraintestinal infections. PLoS Pathog. 6:e1001125. http://dx.doi.org/10.1371/journal.ppat.1001125.
19. Dong T, Schellhorn HE. 2010. Role of RpoS in virulence of pathogens. Infect. Immun. 78:887-897. http://dx.doi.org/10.1128/IAI.00882-09.
20. Demple B, Halbrook J, Linn S. 1983. Escherichia coli xth mutants are hypersensitive to hydrogen peroxide. J. Bacteriol. 153:1079-1082.
21. Huang CK, Zhan L, Hannigan MO, Ai Y, Leto TL. 2000. P47(phox)-deficient NADPH oxidase defect in neutrophils of diabetic mouse strains, C57BL/6J-m db/db and db/+. J. Leukoc. Biol. 67:210-215.
22. Jackson SH, Gallin JI, Holland SM. 1995. The p47phox mouse knockout model of chronic granulomatous disease. J. Exp. Med. 182:751-758. http: //dx.doi.org/10.1084/jem.182.3.751.
23. Welch RA, Burland V, Plunkett G III, Redford P, Roesch P, Rasko D, Buckles EL, Liou SR, Boutin A, Hackett J, Stroud D, Mayhew GF, Rose DJ, Zhou S, Schwartz DC, Perna NT, Mobley HL, Donnenberg MS, Blattner FR. 2002. Extensive mosaic structure revealed by the complete genome sequence of uropathogenic Escherichia coli. Proc. Natl. Acad. Sci. U. S. A. 99:17020-17024. http://dx.doi.org/10.1073/pnas.252529799.
24. Culham DE, Lu A, Jishage M, Krogfelt KA, Ishihama A, Wood JM. 2001. The osmotic stress response and virulence in pyelonephritis isolates of Escherichia coli: contributions of RpoS, ProP, ProU and other systems. Microbiology 147:1657-1670.
25. Battaglioli EJ, Baisa GA, Weeks AE, Schroll RA, Hryckowian AJ, Welch RA. 2011. Isolation of generalized transducing bacteriophages for uropathogenic strains of Escherichia coli. Appl. Environ. Microbiol. 77: 6630-6635. http://dx.doi.org/10.1128/AEM.05307-11.
26. Donovan GT, Norton JP, Bower JM, Mulvey MA. 2013. Adenylate cyclase and the cyclic AMP receptor protein (CRP) modulate the stress resistance and virulence capacity of uropathogenic Escherichia coli. Infect. Immun. 81:249-258. http://dx.doi.org/10.1128/IAI.00796-12.
27. Spira B, de Almeida Toledo R, Maharjan RP, Ferenci T. 2011. The uncertain consequences of transferring bacterial strains between laboratories-rpoS instability as an example. BMC Microbiol. 11:248. http://dx.doi.org/10.1186/1471-2180-11-248.
28. Zambrano MM, Siegele DA, Almirón M, Tormo A, Kolter R. 1993. Microbial competition: Escherichia coli mutants that take over stationary phase cultures. Science 259:1757-1760. http://dx.doi.org/10.1126/science.7681219.
29. Snyder E, Gordon DM, Stoebel DM. 2012. Escherichia coli lacking RpoS are rare in natural populations of non-pathogens. G3 (Bethesda) 2:1341-1344.
30. Mongkolsuk S, Helmann JD. 2002. Regulation of inducible peroxide stress responses. Mol. Microbiol. 45:9-15. http://dx.doi.org/10.1046/j.1365-2958.2002.03015.x
31. Zheng M, Wang X, Templeton LJ, Smulski DR, LaRossa RA, Storz G. 2001. DNA microarray-mediated transcriptional profiling of the Escherichia coli response to hydrogen peroxide. J. Bacteriol. 183:4562-4570. http://dx.doi.org/10.1128/JB.183.15.4562-4570.2001.
32. Storz G, Tartaglia LA, Ames BN. 1990. The OxyR regulon. Antonie Van Leeuwenhoek 58:157-161. http://dx.doi.org/10.1007/BF00548927.
33. Johnson JR, Clabots C, Rosen H. 2006. Effect of inactivation of the global oxidative stress regulator oxyR on the colonization ability of Escherichia coli O1:K1:H7 in a mouse model of ascending urinary tract infection. Infect. Immun. 74:461-468. http://dx.doi.org/10.1128/IAI.74.1.461-468.2006.
34. Li B, Smith P, Horvath DJ, Jr, Romesberg FE, Justice SS. 2010. SOS regulatory elements are essential for UPEC pathogenesis. Microb. Infect. 12:662-668.
35. Labat F, Pradillon O, Garry L, Peuchmaur M, Fantin B, Denamur E. 2005. Mutator phenotype confers advantage in Escherichia coli chronic urinary tract infection pathogenesis. FEMS Immunol. Med. Microbiol. 44:317-321. http://dx.doi.org/10.1016/j.femsim.2005.01.003.
36. Alteri CJ, Lindner JR, Reiss DJ, Smith SN, Mobley HL. 2011. The broadly conserved regulator PhoP links pathogen virulence and membrane potential in Escherichia coli. Mol. Microbiol. 82:145-163. http://dx.doi.org/10.1111/j.1365-2958.2011.07804.x.
37. Redford P, Welch RA. 2006. Role of sigma E-regulated genes in Escherichia coli uropathogenesis. Infect. Immun. 74:4030-4038. http://dx.doi.org/10.1128/IAI.01984-05.
38. Redford P, Roesch PL, Welch RA. 2003. degS is necessary for virulence and is among extraintestinal Escherichia coli genes induced in murine peritonitis. Infect. Immun. 71:3088-3096. http://dx.doi.org/10.1128/IAI.71.6.3088-3096.2003.
39. Datsenko KA, Wanner BL. 2000. One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc. Natl. Acad. Sci. U. S. A. 97:6640-6645. http://dx.doi.org/10.1073/pnas.120163297.
40. Adler J. 1966. Chemotaxis in Bacteria. Science 153:708-716. http://dx.doi.org/10.1126/science.153.3737.708.